Tech ventures often think too narrowly about licensing at the start: it certainly wasn’t in the original plan at Infinite Roots, reports an EPO / EIC case study

Tech ventures often miss the chance to collaborate more widely and reap the rewards in different commercial scenario by thinking too narrowly about licensing. It certainly wasn’t in the original model at Infinite Roots in 2018.

Based in Hamburg, it’s a biotech with the ambition of transforming the food chain and creating a alternative to meat by fermenting the roots of mushrooms, the mycelium. So far it has raised €70 million and employs over 70 people.